> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Webinar Explains Indication, Usage Guidance
- URL: https://www.fdaweb.com/webinar-explains-indication-usage-guidance/
- Published: 2018-10-11T12:00:00.000Z
- Updated: 2026-09-15T00:37:34.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5142562

An FDA Webinar provides a detailed explanation of the agency’s July [draft guidance](https://www.fdaweb.com/indications-usage-content-guidance/) on *Indications and Usage Section of Labeling for Human Prescription Drug and Biological Products—Content and Format.* In the [Webinar](https://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm618346.htm?utm%5Fcampaign=SBIA%3A%20Webinar%20Recording%20Available%3A%20Writing%20the%20%E2%80%9CIndications%20and%20Usage%E2%80%9D%20Section%20of%20Labelin&utm%5Fmedium=email&utm%5Fsource=Eloqua&elqTrackId=802E27FA87331AD18C056ECF73E34047&elq=d562e4972beb490a92854b194c85f3be&elqaid=5430&elqat=1&elqCampaignId=4349), CDER Office of Medical Policy special assistant for labeling **Iris Masucci** covers: **(1)** how to write, organize, and format the information in the Indications and Usage section; **(2)** general principles to consider when drafting the Indications and Usage section; and **(3)** when to include limitations of use in the Indications and Usage section.